UniTao Pharma Puts Planned US Facility on Hold

UniTao Pharmaceuticals has idled plans to open a US manufacturing plant in Petersburg, Virginia, where it was expected to make APIs for the ex-China market. The company cited adverse business conditions for the setback, though it did not provide details. In October 2014, UniTao, a division of China's Tenry Pharma, announced it would invest $22.5 million to buy and refurbish a Boehringer Ingelheim facility that was about to be shut down. Apparently, UniTao paid $2.4 million to acquire the plant, but decided to postpone any updates.  More details.... Share this with colleagues: // //